HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fukui, K. Articles by Sasaoka, T. Search for Related Content PubMed PubMed Citation Articles by Fukui, K. Articles by Sasaoka, T. Social Bookmarking                What's this?

Impact of the Liver-Specific Expression of SHIP2 (SH2-Containing Inositol 5'-Phosphatase 2) on Insulin Signaling and Glucose Metabolism in Mice

¹ First Department of Internal Medicine, Toyama Medical & Pharmaceutical University, Toyama, Japan
² Department of Clinical Pharmacology, Toyama Medical & Pharmaceutical University, Toyama, Japan
³ Sainou Hospital, Toyama, Japan

We investigated the role of hepatic SH2-containing inositol 5'-phosphatase 2 (SHIP2) in glucose metabolism in mice. Adenoviral vectors encoding wild-type SHIP2 (WT-SHIP2) and a dominant-negative SHIP2 (IP-SHIP2) were injected via the tail vein into db/+m and db/db mice, respectively. Four days later, amounts of hepatic SHIP2 protein were increased by fivefold. Insulin-induced phosphorylation of Akt in liver was impaired in WT-SHIP2–expressing db/+m mice, whereas the reduced phosphorylation was restored in IP-SHIP2–expressing db/db mice. The abundance of mRNA for glucose-6-phosphatase (G6Pase) and PEPCK was increased, that for glucokinase (GK) was unchanged, and that for sterol regulatory element–binding protein 1 (SREBP)-1 was decreased in hepatic WT-SHIP2–overexpressing db/+m mice. The increased expression of mRNA for G6Pase and PEPCK was partly suppressed, that for GK was further enhanced, and that for SREBP1 was unaltered by the expression of IP-SHIP2 in db/db mice. The hepatic expression did not affect insulin signaling in skeletal muscle and fat tissue in both mice. After oral glucose intake, blood glucose levels and plasma insulin concentrations were elevated in WT-SHIP2–expressing db/+m mice, while elevated values were decreased by the expression of IP-SHIP2 in db/db mice. These results indicate that hepatic SHIP2 has an impact in vivo on the glucose metabolism in both physiological and diabetic states possibly by regulating hepatic gene expression.

Abbreviations: G6Pase, glucose-6-phosphatase; GK, glucokinase; IP-SHIP2, dominant-negative SHIP2; IRS, insulin receptor substrate; PI, phosphatidylinositol; PTEN, 3'-lipid phosphatase; SHIP2, SH2-containing inositol 5'-phosphatase 2; SREBP, sterol regulatory element–binding protein; WT-SHIP2, wild-type SHIP2

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Grempler, D. Zibrova, C. Schoelch, A. van Marle, J. F. Rippmann, and N. Redemann Normalization of Prandial Blood Glucose and Improvement of Glucose Tolerance by Liver-Specific Inhibition of SH2 Domain Containing Inositol Phosphatase 2 (SHIP2) in Diabetic KKAy Mice: SHIP2 Inhibition Causes Insulin-Mimetic Effects on Glycogen Metabolism, Gluconeogenesis, and Glycolysis Diabetes, September 1, 2007; 56(9): 2235 - 2241. [Abstract] [Full Text] [PDF]

				F. M. Smith, L. J. Holt, A. S. Garfield, M. Charalambous, F. Koumanov, M. Perry, R. Bazzani, S. A. Sheardown, B. D. Hegarty, R. J. Lyons, et al. Mice with a Disruption of the Imprinted Grb10 Gene Exhibit Altered Body Composition, Glucose Homeostasis, and Insulin Signaling during Postnatal Life Mol. Cell. Biol., August 15, 2007; 27(16): 5871 - 5886. [Abstract] [Full Text] [PDF]

				R. Buettner, I. Ottinger, C. Gerhardt-Salbert, C. E. Wrede, J. Scholmerich, and L. C. Bollheimer Antisense oligonucleotides against the lipid phosphatase SHIP2 improve muscle insulin sensitivity in a dietary rat model of the metabolic syndrome Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1871 - E1878. [Abstract] [Full Text] [PDF]